Dow Jones

38,686.32

1.51%

Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

Regístrate

SNCE

Science 37 (SNCE)

Science 37 Holdings Inc

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SNCE

1 2 3 4 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
13/05/2024	07:00	GlobeNewswire Inc.	Science 37 Metasite™ Undergoes Successful FDA Inspection, Marking Major Milestone in Virtual Site Quality Assurance and Compliance	NASDAQ:SNCE	Science 37 Holdings Inc
09/05/2024	09:00	GlobeNewswire Inc.	Science 37 Wins 2024 MedTech Breakthrough Award for “Clinical Efficiency Innovation”	NASDAQ:SNCE	Science 37 Holdings Inc
02/05/2024	07:00	GlobeNewswire Inc.	Science 37 Delivers 22x Faster Enrollment than Traditional Methods in Phase 3 Asthma Clinical Trial	NASDAQ:SNCE	Science 37 Holdings Inc
17/04/2024	07:00	GlobeNewswire Inc.	Science 37 Provides Fully Consented Patients to Sites to Supplement Enrollment	NASDAQ:SNCE	Science 37 Holdings Inc
12/03/2024	05:45	PR Newswire (US)	eMed completes tender offer for all outstanding shares of Science 37	NASDAQ:SNCE	Science 37 Holdings Inc
04/03/2024	05:18	Edgar (US Regulatory)	Form SC TO-T/A - Tender offer statement by Third Party: [Amend]	NASDAQ:SNCE	Science 37 Holdings Inc
04/03/2024	05:01	Edgar (US Regulatory)	Form SC 14D9/A - Solicitation, recommendation statements: [Amend]	NASDAQ:SNCE	Science 37 Holdings Inc
19/02/2024	22:16	PR Newswire (US)	Kuehn Law Encourages DFS, SNCE, HRT, and IONM Investors to Contact Law Firm	NASDAQ:SNCE	Science 37 Holdings Inc
12/02/2024	08:03	Edgar (US Regulatory)	Form SC 14D9 - Solicitation, recommendation statements	NASDAQ:SNCE	Science 37 Holdings Inc
12/02/2024	07:16	Edgar (US Regulatory)	Form SC TO-T - Tender offer statement by Third Party	NASDAQ:SNCE	Science 37 Holdings Inc
12/02/2024	06:45	PR Newswire (US)	eMed commences tender offer for Science 37	NASDAQ:SNCE	Science 37 Holdings Inc
09/02/2024	06:49	Edgar (US Regulatory)	Form SC14D9C - Written communication relating to third party tender offer	NASDAQ:SNCE	Science 37 Holdings Inc
09/02/2024	06:40	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SNCE	Science 37 Holdings Inc
30/01/2024	09:11	Edgar (US Regulatory)	Form SC TO-C - Written communication relating to an issuer or third party	NASDAQ:SNCE	Science 37 Holdings Inc
12/12/2023	07:00	GlobeNewswire Inc.	Science 37 Receives Top Honors in Everest PEAK Matrix®	NASDAQ:SNCE	Science 37 Holdings Inc
07/12/2023	15:59	GlobeNewswire Inc.	Science 37 Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:SNCE	Science 37 Holdings Inc
05/12/2023	06:00	GlobeNewswire Inc.	Science 37 Holdings, Inc. Announces 1-for-20 Reverse Stock Split effective December 8, 2023	NASDAQ:SNCE	Science 37 Holdings Inc
07/11/2023	05:39	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:SNCE	Science 37 Holdings Inc
07/11/2023	05:04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SNCE	Science 37 Holdings Inc
27/10/2023	15:11	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:SNCE	Science 37 Holdings Inc
10/10/2023	15:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SNCE	Science 37 Holdings Inc
03/10/2023	15:15	Edgar (US Regulatory)	Form PRE 14A - Other preliminary proxy statements	NASDAQ:SNCE	Science 37 Holdings Inc
20/09/2023	06:59	GlobeNewswire Inc.	Science 37 Chief Delivery Officer, Darcy Forman, Named to Prestigious PharmaVoice 100 List	NASDAQ:SNCE	Science 37 Holdings Inc
13/09/2023	06:59	GlobeNewswire Inc.	Science 37 Recognized in the Gartner® Hype Cycle™ for Life Science Clinical Development, 2023	NASDAQ:SNCE	Science 37 Holdings Inc
12/09/2023	06:59	GlobeNewswire Inc.	Science 37 Named Market Leader for Global Decentralized Clinical Trials by Frost & Sullivan	NASDAQ:SNCE	Science 37 Holdings Inc
15/08/2023	06:59	GlobeNewswire Inc.	Science 37 Recognized as Best Digital Health Solution Nominee at 2023 Prix Galien USA Awards	NASDAQ:SNCE	Science 37 Holdings Inc
11/07/2023	06:59	GlobeNewswire Inc.	Synlogic Partners with Science 37 on Pivotal Study for Investigational Drug for Phenylketonuria (PKU)	NASDAQ:SNCE	Science 37 Holdings Inc
27/06/2023	15:45	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:SNCE	Science 37 Holdings Inc
22/05/2023	15:59	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:SNCE	Science 37 Holdings Inc
18/05/2023	06:59	GlobeNewswire Inc.	Science 37 Wins 2023 MedTech Breakthrough Award for "Best Overall Clinical Trial Platform"	NASDAQ:SNCE	Science 37 Holdings Inc